Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2015 Feb;135(2):580-589.
doi: 10.1097/PRS.0000000000000911.

Intralesional cryotherapy for treatment of keloid scars: a prospective study

Michiel C E van Leeuwen  1 , Martijn B A van der Wal, Anne-Eva J Bulstra, Francisca Galindo-Garre, Jonneke Molier, Paul P M van Zuijlen, Paul A M van Leeuwen, Frank B Niessen
Affiliations
Clinical Trial

Intralesional cryotherapy for treatment of keloid scars: a prospective study

Michiel C E van Leeuwen et al. Plast Reconstr Surg. 2015 Feb.

Abstract

Background: Intralesional cryotherapy is a novel treatment for keloid scars in which the scar is frozen from inside. Published results are promising, but the treatment has only been tested in a Caucasian patient population. Therefore, the authors evaluated intralesional cryotherapy in a patient population including different Fitzpatrick skin types (I through VI).

Methods: This prospective multicenter study with a 1-year follow-up included 27 patients with 29 keloid scars. Intralesional cryotherapy was administered with a disposable liquid nitrogen-based device called CryoShape. Scar assessment was performed using the Patient and Observer Scar Assessment Scale and four objective devices to determine scar color, scar elasticity, scar volume, and patient skin type.

Results: Keloid scars showed an average volume decrease of 63 percent (range, 16 to 100 percent) after 12 months, compared with baseline (p < 0.01). Recurrence was seen in seven keloids (24 percent) and hypopigmentation recovered in 69 percent of all keloid scars within 12 months. Scar assessment with the Patient and Observer Scar Assessment Scale showed an overall improvement according to both doctors and patients. In addition, complaints of pain and itching were reduced. When analyzing the results per Fitzpatrick skin type, African American patients showed a higher incidence of persistent hypopigmentation (p = 0.02).

Conclusions: Intralesional cryotherapy for the treatment of keloid scars shows favorable results in terms of reduction of volume and complaints of pain and pruritus. However, no complete eradication was obtained in some cases and recurring scars were seen. In addition, persistent hypopigmentation proved a problem in non-Caucasian patients.

Clinical question/level of evidence: Therapeutic, IV.

Trial registration: ClinicalTrials.gov NCT01994616.

PubMed Disclaimer

Comment in

References

    1. Niessen FB, Spauwen PH, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloids: A review. Plast Reconstr Surg. 1999;104:1435–1458
    1. Bock O, Schmid-Ott G, Malewski P, Mrowietz U. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res. 2006;297:433–438
    1. Bischof M, Krempien R, Debus J, Treiber M. Postoperative electron beam radiotherapy for keloids: Objective findings and patient satisfaction in self-assessment. Int J Dermatol. 2007;46:971–975
    1. Mustoe TA, Cooter RD, Gold MH, et al.International Advisory Panel on Scar Management. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110:560–571
    1. Lawrence WT. In search of the optimal treatment of keloids: Report of a series and a review of the literature. Ann Plast Surg. 1991;27:164–178

MeSH terms

Associated data